CSF2 and neoplasm: Further supporting the therapeutic potential of targeting MDSCs, the neutralization of GM-CSF in a preclinical model of MPM inhibits the accumulation of tumor-infiltrating PMN-MDSC, boosting anti-tumor immunity [83].